Editorial
doi: 10.1016/j.endonu.2014.11.002.
Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird
[Article in
English,
Spanish]
Affiliations
- PMID: 25434595
- DOI: 10.1016/j.endonu.2014.11.002
Item in Clipboard
Editorial
Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird
[Article in
English,
Spanish]
Endocrinol Nutr.
2014 Dec.
No abstract available
Similar articles
-
Nonincretin drugs in later-stage development.Am J Manag Care. 2014 Jan;20(1 Spec No.):E2. Am J Manag Care. 2014. PMID: 25618226 No abstract available.
-
New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).Cardiol Rev. 2014 Jan-Feb;22(1):43-50. doi: 10.1097/CRD.0000000000000001. Cardiol Rev. 2014. PMID: 24304809 Review.
-
Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.Expert Opin Drug Saf. 2017 Jan;16(1):27-39. doi: 10.1080/14740338.2017.1247807. Epub 2016 Oct 24. Expert Opin Drug Saf. 2017. PMID: 27732121 Review.
-
Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.Drugs Today (Barc). 2011 Dec;47(12):903-14. doi: 10.1358/dot.2011.47.12.1718738. Drugs Today (Barc). 2011. PMID: 22348915 Review.
-
Two new drugs approved for obesity.S D Med. 2012 Sep;65(9):356-7. S D Med. 2012. PMID: 23066610 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
